Artemis Medicare Services Limited
NSE: ARTEMISMED BSE: ARTEMISMED
Prev Close
249.5
Open Price
249.5
Volume
169,194
Today Low / High
249.5 / 258.85
52 WK Low / High
200.01 / 350
Range
241 - 266
Prev Close
249.55
Open Price
248
Volume
19,487
Today Low / High
248 / 257.95
52 WK Low / High
248 / 257.95
Range
241 - 266
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 253.55 (target range: 241 - 266), reflecting a change of 4.05 (1.62325%). On the BSE, it is listed at 253.45 (target range: 241 - 266), showing a change of 3.9 (1.56281%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Artemis Medicare Services Limited Graph
Artemis Medicare Services Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Artemis Medicare Services Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 253.55, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 253.45 | 255.98 | 230.39 - 281.58 |
| 258.52 | 206.82 - 310.22 | ||
| 261.05 | 182.74 - 339.37 | ||
| Bearish Scenario | 253.45 | 250.92 | 225.82 - 276.01 |
| 248.38 | 198.70 - 298.06 | ||
| 245.85 | 172.09 - 319.60 |
Overview of Artemis Medicare Services Limited
ISIN
INE025R01021
Industry
Medical - Care Facilities
Vol.Avg
109,148
Market Cap
34,954,185,000
Last Dividend
0.45
Official Website
IPO Date
2020-01-24
DCF Diff
330.04
DCF
-77
Financial Ratios Every Investor Needs
Stock Dividend of ARTEMISMED
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-07-11 | July 11, 25 | 0.45 | 0.45 | 2025-07-11 | 2025-08-29 | |
| 2024-07-05 | July 05, 24 | 0.45 | 0.45 | 2024-07-05 | 2024-08-23 | |
| 2023-07-14 | July 14, 23 | 0.45 | 0.45 | 2023-07-14 | 2023-08-31 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 936.92 Cr | 713.59 Cr | 223.33 Cr | 0.2384 | 0.00 Cr | 0.00 Cr | 223.33 Cr | 82.63 Cr | 5.37 | 151.79 Cr | 0.0882 |
| 2024-03-31 | 878.57 Cr | 701.00 Cr | 177.57 Cr | 0.2021 | 8.58 Cr | 4.21 Cr | 160.47 Cr | 49.14 Cr | 3.62 | 124.60 Cr | 0.0559 |
| 2023-03-31 | 736.55 Cr | 632.90 Cr | 103.65 Cr | 0.1407 | 3.64 Cr | 3.68 Cr | 64.77 Cr | 38.60 Cr | 2.89 | 101.29 Cr | 0.0524 |
| 2022-03-31 | 552.75 Cr | 457.30 Cr | 95.44 Cr | 0.1727 | 3.21 Cr | 3.65 Cr | 45.36 Cr | 31.81 Cr | 2.40 | 71.35 Cr | 0.0576 |
| 2021-03-31 | 407.55 Cr | 370.38 Cr | 37.17 Cr | 0.0912 | 3.31 Cr | 2.65 Cr | 14.44 Cr | 6.49 Cr | 0.49 | 35.95 Cr | 0.0159 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 395.54 Cr | 1,357.41 Cr | 513.86 Cr | 837.6759 Cr | 290.28 Cr | -105.26 Cr | 9.98 Cr | 733.43 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 216.1300 Cr |
| 2024-03-31 | 14.61 Cr | 971.51 Cr | 516.83 Cr | 448.3529 Cr | 320.26 Cr | 305.65 Cr | 10.08 Cr | 709.01 Cr | 0.88 Cr | 0.00 Cr | 0.85 Cr | 184.6490 Cr |
| 2023-03-31 | 22.87 Cr | 904.95 Cr | 497.26 Cr | 403.1475 Cr | 285.86 Cr | 262.99 Cr | 13.99 Cr | 654.43 Cr | 13.53 Cr | 39.37 Cr | 1.18 Cr | 205.7946 Cr |
| 2022-03-31 | 15.70 Cr | 709.66 Cr | 348.40 Cr | 359.4248 Cr | 201.20 Cr | 185.50 Cr | 12.40 Cr | 511.64 Cr | 10.80 Cr | 14.96 Cr | 0.48 Cr | 138.1568 Cr |
| 2021-03-31 | 19.16 Cr | 600.09 Cr | 278.35 Cr | 320.1939 Cr | 146.69 Cr | 127.53 Cr | 9.62 Cr | 426.70 Cr | 9.40 Cr | 16.13 Cr | 2.79 Cr | 118.8180 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 145.6167 Cr | -385.3843 Cr | 266.7472 Cr | 52.4653 Cr | 26.9796 Cr | 41.5884 Cr | -93.1514 Cr | 82.6258 Cr | 309.2577 Cr | -5.9755 Cr | 0.1054 Cr |
| 2024-03-31 | 108.8544 Cr | -89.1040 Cr | -30.1241 Cr | 36.3014 Cr | -8.2598 Cr | 14.6088 Cr | -72.5530 Cr | 49.1406 Cr | 8.1448 Cr | -6.1137 Cr | 3.9084 Cr |
| 2023-03-31 | 112.7043 Cr | -157.7160 Cr | 52.1816 Cr | -33.7676 Cr | 7.1699 Cr | 22.8686 Cr | -146.4719 Cr | 38.5976 Cr | 55.2820 Cr | 0.0000 Cr | -1.5943 Cr |
| 2022-03-31 | 51.5803 Cr | -107.8807 Cr | 52.8371 Cr | -57.3200 Cr | -3.4633 Cr | 15.6987 Cr | -108.9003 Cr | 31.8144 Cr | 56.1838 Cr | 0.0000 Cr | -2.7725 Cr |
| 2021-03-31 | 18.2388 Cr | -37.8469 Cr | 27.1619 Cr | -16.2624 Cr | 7.5538 Cr | 19.1620 Cr | -34.5012 Cr | 6.4858 Cr | 39.7275 Cr | 0.0000 Cr | 1.1292 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 239.90 Cr | 185.06 Cr | 54.84 Cr | 0.2286 | 54.84 Cr | 23.03 Cr | 1.47 | 35.44 Cr | 0.0960 |
| 2024-12-31 | 232.39 Cr | 177.91 Cr | 54.48 Cr | 0.2344 | 54.48 Cr | 20.67 Cr | 1.32 | 33.80 Cr | 0.0889 |
| 2024-09-30 | 241.42 Cr | 180.77 Cr | 60.65 Cr | 0.2512 | 60.65 Cr | 22.26 Cr | 1.42 | 42.08 Cr | 0.0922 |
| 2024-06-30 | 223.20 Cr | 169.84 Cr | 53.36 Cr | 0.2391 | 53.36 Cr | 16.67 Cr | 1.12 | 33.15 Cr | 0.0747 |
| 2024-03-31 | 225.24 Cr | 181.21 Cr | 44.04 Cr | 0.1955 | 26.91 Cr | 14.18 Cr | 1.04 | 39.85 Cr | 0.0630 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 395.54 Cr | 0.00 Cr | 395.54 Cr | 101.32 Cr | 9.98 Cr | 538.86 Cr | 733.43 Cr | 1,357.41 Cr | 513.86 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 375.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -798.56 Cr |
| 2024-09-30 | 375.01 Cr | 0.00 Cr | 375.01 Cr | 106.55 Cr | 10.05 Cr | 515.80 Cr | 728.45 Cr | 1,339.05 Cr | 540.49 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 61.21 Cr | 0.00 Cr | 0.00 Cr | 61.21 Cr | 0.00 Cr | 0.00 Cr | -454.68 Cr |
| 2024-03-31 | 14.61 Cr | 46.60 Cr | 61.21 Cr | 104.61 Cr | 10.08 Cr | 180.10 Cr | 704.11 Cr | 971.51 Cr | 516.83 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 23.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 20.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 22.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 16.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 14.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2021-09-23 | September 23, 21 | 10:1 |
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,261.10 | ₹1,225,974,581,700.00 | ₹823,912.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,360.50 | ₹1,058,329,492,500.00 | ₹517,907.00 |
| Fortis Healthcare Limited | FORTIS | ₹799.25 | ₹603,400,181,500.00 | ₹2,210,644.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,984.50 | ₹405,554,404,500.00 | ₹315,225.00 |
| Global Health Limited | MEDANTA | ₹1,326.20 | ₹356,200,570,094.00 | ₹214,915.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹598.55 | ₹310,121,324,550.00 | ₹1,257,707.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹715.20 | ₹286,179,412,800.00 | ₹365,991.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,526.60 | ₹155,028,785,528.00 | ₹162,942.00 |
| HealthCare Global Enterprises Limited | HCG | ₹569.95 | ₹79,459,579,250.00 | ₹228,365.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹619.10 | ₹59,652,981,181.00 | ₹434,543.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹495.35 | ₹45,410,220,550.00 | ₹137,687.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹253.55 | ₹35,218,095,000.00 | ₹169,194.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born:
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born: 1969
Gender: male
Year Born:
FAQs about Artemis Medicare Services Limited
The CEO is Devlina Chakravarty DMRD, DNB, Radiology.
The current price is ₹251.65.
The range is ₹190.05-350.
The market capitalization is ₹3,495.42 crores.
The P/E ratio is 48.37.
The company operates in the Healthcare sector.
Overview of Artemis Medicare Services Limited (ISIN: INE025R01021) is a leading Medical - Care Facilities in India. With a market capitalization of ₹3,495.42 crores and an average daily volume of 109,148 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.45.